Skip to main content

www.hksccm.org

2010 Jan – 2010 Jan – Coagulopathy in Critically III Patients: Part 2–Soluble Clotting Factors and Hemostatic Testing

Arthur P. Wheeler, MD, FCCP and Todd W. Rice, MD, MSc. CHEST January 2010 vol. 137 no. 1 185-194
This manuscript provides an overview of how to interpret in vitro clotting studies and how to select studies to evaluate patients with bleeding disorders in the ICU.


It provides a practical approach to understanding the complex subject of clotting factor abnormalities, including the most common problems of preanalytical error and anticoagulation therapy. Limitations and pitfalls of diagnostic testing are highlighted.

Weblink here

Part 1 here